AksharChem (I) Q4 FY17 Earnings Call Analysis
Revenue, margin, capex, fundraise and order book outlook from management commentary.
Management growth scorecard
Revenue
Category 3
Margin
Category 3
Fundraise
Yes
Order
Yes
Capex
Yes
3 of 5 growth signals are positive.
Full analysisRevenue guidance
Category 3- AksharChem expects around 10% revenue growth in the coming financial year (FY 2018), driven mainly by volume growth in Vinyl Sulphone and expanded capacity in Pigment Green. (Page 3, 5)
- Most capacity expansion-related revenue is anticipated from FY 2019 onwards, as the ongoing Rs. 175 crore expansion projects are scheduled for commissioning in the next 12-15 months. (Pages 3, 5, 10)
- Vinyl Sulphone utilization is expected to increase from around 76% to above 85% in the current year. (Page 15)
- CPC Green Pigment capacity expansion (480 tonnes) is expected to come on stream from Q2 FY 2018, with projected 70% utilization in the last two quarters. (Pages 9, 16)
- The Precipitated Silica division aims for approximately 25% margins, representing a new product line contributing to growth. (Page 18)
See what AksharChem (I) management said on margin guidance — free account, 30 seconds.
Fundraise plans
Yes- Currently, AksharChem has begun its Rs. 175 crore expansion using internal accruals.
- The company sees no immediate need for debt or equity funding at present.
- For future fundraising related to expansions, they are open to considering a combination of debt and equity.
- The decision to raise funds via debt or equity will depend on the requirements as the project progresses.
- As of now, strong internal accruals are supporting expansion activities without external fundraising.
See what AksharChem (I) management said on order book — free account, 30 seconds.
Capex plans
Yes- Approved capital expenditure plan up to Rs. 175 crores in Specialty Chemicals, Dyes and Intermediates, and Organic Pigments.
- Backward integration in the CPC Green business by manufacturing CPC Blue Crude to improve margins.
- Capacity expansion of CPC Blue planned at 150 tonnes per month.
- CAPEX for H-Acid plant is Rs. 25 crores with a capacity of 1,200 tonnes per annum.
- Expansion work has started and is on schedule for commissioning in the next 12 to 15 months (around 2019-2020).
- Specialty Chemicals capacity expansion includes 10,000 tonnes with projected 25% EBITDA margins.
- CPC Green expansion of 480 tonnes expected to come on stream from Q2 FY 2018.
- Expansion primarily funded through internal accruals, with options of debt and equity open for future funding.
Track AksharChem (I) — get its next earnings analysis in your feed
Margin guidance
Category 3- Revenue growth is expected at around 10% going forward, with major contributions from Vinyl Sulphone and Pigment Green businesses (Page 3, 5).
- EBITDA margins are projected to be sustainable between 25% and 30% (Pages 3, 8, 16).
- Expansion projects, including backward integration in CPC Green with CPC Blue Crude, will improve margins by 2-3% EBITDA once fully operational by 2019-2020 (Pages 3, 10).
- Most capacity expansions’ revenue impact will be visible from FY19 onwards (Page 5).
- Vinyl Sulphone volume and capacity utilization improvements are expected to support growth (Pages 3, 5).
- The Precipitated Silica division venture is projected to deliver approximately 25% margins (Page 18).
- Focus remains on specialty chemicals with improved efficiency and technology, aiding margin protection (Pages 16, 18).
Order book
Yes- AksharChem currently has a strong order book position with about six months of orders in hand.
- The company maintains full order capacity and strong demand, reflecting confidence in their product mix.
- They have significant repeat business due to unique products with long-term customer relationships.
- The company is operating at full capacity for the CPC Green business.
- Post expansion, AksharChem aims to dominate approximately 17%-18% of the global CPC Green market.
- Expansions underway include capacity increases and backward integration to improve margins.
- Specific long-term contracts account for around 30%-35% of business but details are closely held.
How does AksharChem (I) rank vs peers in Chemicals & Petrochemicals?
Pro featureHow does AksharChem (I) rank in Chemicals & Petrochemicals?
Compare AksharChem (I) against every Chemicals & Petrochemicals company (Q4 FY17) on revenue, margins and earnings-call signals.
Continue your research
What AksharChem (I)'s management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Solar Industries (Q1 FY27)
EBITDA margin improvement potential in explosive business to reach mid-teens (18-19% global benchmarks), with combined Solar-BME margins currently at 13-14%…
- Sudarshan Chem. (Q1 FY27)
The net debt has already been reduced significantly from Rs.922 Crores at acquisition to Rs.531 Crores. Key concall takeaways from Sudarshan Chemical…
- Indo Borax & Ch. (Q1 FY27)
250-260 crores in FY27 with about 20% EBITDA margin, growing at 11-12% annually in absolute terms. Key concall takeaways from Indo Borax & Chemicals Ltd's Q1…
- SRF (Q1 FY27)
Chemicals business is guided for 15-20% growth in FY27, with a strong Q1 performance positioning the company to possibly hit the higher end of this range (Page…